Sign In
Buy MDAI
$1.94
-0.120 (-5.83%)
At Close: Jun 03, 2026
Spectral AI founder and ex-boss returns as director
08:46am, Monday, 12'th Feb 2024
Spectral AI Inc (NASDAQ:MDAI), the medical technology company, appointed founder and former boss Michael DiMaio as a non-executive director last week, replacing the position left by Michael Murphy. Di
Spectral AI closing in on commercial revenue from DeepView system
11:29am, Monday, 05'th Feb 2024
Spectral AI Inc (NASDAQ:MDAI) has told investors that interim results of ongoing clinical trials designed to validate its DeepView System will be “promising”. This includes tests of the medical im
Spectral AI moves towards commercialization of burn care predictive software with UKCA mark application
10:47am, Monday, 29'th Jan 2024
Spectral AI Inc (NASDAQ:MDAI) subsidiary Spectral MD announced that it has submitted an application in the United Kingdom for its predictive software DeepView AI-Burn to be registered as UK Conformity
Spectral AI initiates pivotal study for DeepView AI in burn care
08:46am, Thursday, 11'th Jan 2024
Spectral AI Inc (NASDAQ:MDAI) said it has started enrollment for a pivotal study of DeepView AI, utilizing its proprietary imaging technology for burn size and healing assessment. The study is a cruc
Spectral AI taps experienced exec as new CFO
09:23am, Tuesday, 19'th Dec 2023
Spectral AI Inc (NASDAQ:MDAI) announced that it has appointed Peter Carlson as its chief financial officer. Carlson has previously served as CFO at MiMedx Group, chief operating officer at Brighthouse
Spectral AI appoints IP veteran Erich Spangenberg as Executive Committee chairman
09:31am, Monday, 27'th Nov 2023
Spectral AI Inc (NASDAQ:MDAI) has announced the appointment of Erich Spangenberg, the company's largest shareholder, to its board of directors, who will serve as Executive Committee chairman as well
Spectral AI wraps up “extraordinary” 3Q amid progress with DeepView System
08:16am, Tuesday, 14'th Nov 2023
Spectral AI Inc (NASDAQ:MDAI) told investors it had an “extraordinary” third quarter, highlighted by its listing on Nasdaq and the continued progress made with its DeepView System Wound Healing As
Spectral AI Schedules 2023 Third Quarter Financial Results and Conference Call
08:00am, Wednesday, 01'st Nov 2023
DALLAS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster a
Spectral AI taps Paul Chadwick to lead DeepView global expansion
08:43am, Tuesday, 24'th Oct 2023
Spectral AI Inc (NASDAQ:MDAI) is beefing up its executive team in the UK with the addition of Prof Paul Chadwick. Chadwick, a distinguished clinical scientist and key opinion leader in wound care, wil
Spectral AI provides positive 2023 and 2024 revenue guidance
09:02am, Monday, 23'rd Oct 2023
Spectral AI Inc (NASDAQ:MDAI) has announced that its full-year 2023 revenue is expected to approximately $17.4 million, while its revenue in 2024 is expected to be about $28.0 million. The predictiv
Spectral AI shares surge as wound imaging device wins regulatory approvals in US and UK
09:01am, Thursday, 19'th Oct 2023
Spectral AI Inc (NASDAQ:MDAI) shares surged in pre-market trade after the company announced that its DeepView SnapShot Wound Imaging System is now United Kingdom Conformity Assessed (UKCA)-marked for
Spectral AI expands diabetic foot ulcer study to additional clinical sites
08:45am, Monday, 16'th Oct 2023
Spectral AI Inc (NASDAQ:MDAI) announced it has added seven clinical sites to its multi-centre study of its DeepView Wound Imaging System for diabetic foot ulcers. The company said that its proprietary
Are Penny Stocks Worth It? 4 To Watch With Big News
02:10pm, Wednesday, 04'th Oct 2023
Penny stocks, defined as stocks trading under $5 per share, are known for their volatility and potential for significant returns. However, the low price of these stocks also makes them susceptible to
